Medtecs International Corporation Limited (9103.TW)

TWD 5.04

(-1.95%)

Net Income Summary of Medtecs International Corporation Limited

  • Medtecs International Corporation Limited's latest annual net income in 2023 was -21.06 Million USD , up 28.01% from previous year.
  • Medtecs International Corporation Limited's latest quarterly net income in 2024 Q2 was -3.87 Million USD , up 75.31% from previous quarter.
  • Medtecs International Corporation Limited reported an annual net income of -29.26 Million USD in 2022, down -268.74% from previous year.
  • Medtecs International Corporation Limited reported an annual net income of 17.34 Million USD in 2021, down -86.83% from previous year.
  • Medtecs International Corporation Limited reported a quarterly net income of -21.06 Million USD for 2023 FY, up 28.01% from previous quarter.
  • Medtecs International Corporation Limited reported a quarterly net income of -5.35 Million USD for 2023 Q2, up 78.48% from previous quarter.

Annual Net Income Chart of Medtecs International Corporation Limited (2023 - 2009)

Historical Annual Net Income of Medtecs International Corporation Limited (2023 - 2009)

Year Net Income Net Income Growth
2023 -21.06 Million USD 28.01%
2022 -29.26 Million USD -268.74%
2021 17.34 Million USD -86.83%
2020 131.71 Million USD 11234.85%
2019 1.16 Million USD 27.13%
2018 914 Thousand USD 3.51%
2017 883 Thousand USD -13.52%
2016 1.02 Million USD 92.64%
2015 530 Thousand USD 38.38%
2014 383 Thousand USD -37.52%
2013 613 Thousand USD -53.17%
2012 1.3 Million USD -24.03%
2011 1.72 Million USD 22.98%
2010 1.4 Million USD -21.6%
2009 1.78 Million USD 0.0%

Peer Net Income Comparison of Medtecs International Corporation Limited

Name Net Income Net Income Difference
Nang Kuang Pharmaceutical Co., Ltd. 198.4 Million TWD 110.617%
Maxigen Biotech Inc. 165.82 Million TWD 112.704%
SciVision Biotech Inc. 177.9 Million TWD 111.841%
Bionime Corporation 6.2 Million TWD 439.282%
Pegavision Corporation 1.65 Billion TWD 101.272%
Visco Vision Inc. 301.61 Million TWD 106.984%